Wolnei Caumo Selected Research

Brain-Derived Neurotrophic Factor (BDNF)

2/2022	Evidence of Anti-Inflammatory Effect of Transcranial Direct Current Stimulation in a CFA-Induced Chronic Inflammatory Pain Model in Wistar Rats.
1/2022	Impact of Bifrontal Home-Based Transcranial Direct Current Stimulation in Pain Catastrophizing and Disability due to Pain in Fibromyalgia: A Randomized, Double-Blind Sham-Controlled Study.
11/2021	Dysfunctional eating behavior in fibromyalgia and its association with serum biomarkers of brain plasticity (BDNF and S100B): an exploratory study.
5/2021	Mapping of predictors of the disengagement of the descending inhibitory pain modulation system in fibromyalgia: an exploratory study.
10/2020	Brain-Derived Neurotrophic Factor Modulates the Effect of Sex on the Descending Pain Modulatory System in Healthy Volunteers.
5/2020	Transcranial direct current stimulation combined with exercise modulates the inflammatory profile and hyperalgesic response in rats subjected to a neuropathic pain model: Long-term effects.
1/2020	Pain catastrophizing is associated with the Val66Met polymorphism of the brain-derived neurotrophic factor in fibromyalgia.
1/2020	Large Treatment Effect With Extended Home-Based Transcranial Direct Current Stimulation Over Dorsolateral Prefrontal Cortex in Fibromyalgia: A Proof of Concept Sham-Randomized Clinical Study.
1/2020	The Brief Measure of Emotional Preoperative Stress (B-MEPS) as a new predictive tool for postoperative pain: A prospective observational cohort study.
1/2019	PER3 variable number tandem repeat (VNTR) polymorphism modulates the circadian variation of the descending pain modulatory system in healthy subjects.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wolnei Caumo Research Topics

Disease

75	Pain (Aches) 02/2022 - 01/2009
27	Chronic Pain 01/2022 - 01/2012
22	Fibromyalgia (Fibrositis) 01/2022 - 07/2014
16	Neuralgia (Stump Neuralgia) 12/2021 - 01/2016
14	Hyperalgesia 02/2022 - 01/2016
8	Myofascial Pain Syndromes (Myofascial Pain Syndrome) 01/2018 - 10/2013
6	Inflammation (Inflammations) 02/2022 - 01/2012
4	Obesity 12/2020 - 01/2014
4	Osteoarthritis 01/2019 - 08/2012
3	Decapitation 02/2022 - 01/2015
3	Intractable Pain 01/2021 - 01/2017
3	Knee Osteoarthritis 01/2019 - 01/2016
3	Tension-Type Headache (Tension Headache) 01/2019 - 05/2015
3	Endometriosis 01/2019 - 06/2013
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 07/2018 - 02/2016
3	Postoperative Pain 01/2017 - 01/2009
2	Mental Disorders (Mental Disorder) 01/2022 - 01/2021
2	Fatigue 05/2021 - 01/2019
2	Migraine Disorders (Migraine) 01/2021 - 01/2019
2	Schizophrenia (Dementia Praecox) 01/2021 - 01/2018
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2021 - 07/2014
2	Stroke (Strokes) 01/2021 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2019
2	Musculoskeletal Pain 01/2019 - 01/2016
2	Facial Pain (Myofacial Pain) 01/2019 - 10/2016
2	Headache (Headaches) 01/2019 - 05/2015
2	Sleep Deprivation 01/2019 - 11/2011
2	Mood Disorders (Mood Disorder) 01/2018 - 11/2011
1	Depressive Disorder (Melancholia) 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Alcoholism (Alcohol Abuse) 01/2021
1	Epilepsy (Aura) 01/2021
1	Tonic-Clonic Epilepsy (Epilepsy, Tonic Clonic) 01/2021
1	Temporal Lobe Epilepsy 01/2021
1	Tourette Syndrome (Tourette's Syndrome) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Substance-Related Disorders (Drug Abuse) 01/2021
1	Acute Pain 01/2021
1	Hypertriglyceridemia 12/2020
1	Heart Diseases (Heart Disease) 12/2020
1	Hyperglycemia 12/2020
1	Anxiety Disorders (Anxiety Disorder) 01/2020
1	Cognitive Dysfunction 01/2020
1	Feeding and Eating Disorders (Eating Disorder) 02/2019
1	Neoplasms (Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

37	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2022 - 04/2012
23	salicylhydroxamic acid (SHAM)IBA 02/2022 - 03/2014
19	Analgesics (Analgesic Drugs)IBA 05/2021 - 01/2009
15	MelatoninIBA 01/2020 - 01/2009
13	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2016
11	3- (3,5- dichlorophenyl)- 1- methyl- 2,5- pyrrolidinedione (DPMS)IBA 01/2022 - 01/2017
8	Morphine (MS Contin)FDA LinkGeneric 01/2022 - 01/2009
7	Opioid Analgesics (Opioids)IBA 01/2022 - 10/2016
7	Freund's AdjuvantIBA 12/2020 - 01/2012
6	Interleukin-10 (Interleukin 10)IBA 02/2022 - 11/2015
6	Nerve Growth Factor (NGF)IBA 11/2020 - 10/2016
4	Nerve Growth Factors (Neurotrophins)IBA 01/2021 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2015
3	InterleukinsIBA 11/2020 - 11/2015
3	Pain-FreeIBA 10/2020 - 11/2015
3	Hypnotics and Sedatives (Sedatives)IBA 01/2020 - 09/2013
3	Anti-Anxiety Agents (Anxiolytics)IBA 01/2016 - 12/2008
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 12/2020 - 11/2020
2	Interleukin-6 (Interleukin 6)IBA 11/2020 - 01/2016
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019 - 01/2019
2	Ketamine FDA LinkGeneric 01/2018 - 01/2017
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018 - 01/2017
2	CytokinesIBA 11/2017 - 03/2016
2	Formaldehyde (Formol)FDA Link 10/2016 - 01/2011
2	Therapeutic UsesIBA 02/2016 - 11/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2015 - 01/2013
2	Lidocaine (Xylocaine)FDA LinkGeneric 06/2015 - 03/2014
2	CorticosteroneIBA 01/2014 - 12/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2013 - 01/2013
1	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 01/2022
1	SolutionsIBA 12/2021
1	Calcium-Binding ProteinsIBA 11/2021
1	Tramadol (K315)FDA LinkGeneric 11/2021
1	Oxyhemoglobins (Oxyhemoglobin)IBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Thiobarbituric Acid Reactive SubstancesIBA 12/2020
1	NAD (NADH)IBA 12/2020
1	nicotinamide-beta-ribosideIBA 12/2020
1	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 12/2020
1	Adenosine (Adenocard)FDA LinkGeneric 11/2020
1	Interleukin-4 (Interleukin 4)IBA 05/2020
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2020
1	6-sulfatoxymelatoninIBA 01/2019

Therapy/Procedure

40	Transcranial Direct Current Stimulation 02/2022 - 01/2012
14	Transcranial Magnetic Stimulation 01/2021 - 10/2013
14	Therapeutics 01/2021 - 11/2011
8	Analgesia 01/2021 - 06/2010
3	Hysterectomy 01/2013 - 12/2008
2	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 01/2021 - 06/2010
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2019
2	Adjuvant Chemotherapy 01/2020 - 01/2019
2	Aftercare (After-Treatment) 01/2019 - 03/2016
2	Electroacupuncture 06/2018 - 05/2015
1	Euthanasia (Mercy Killing) 02/2022
1	Oral Administration 12/2020